Cargando…
Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods
Lung cancer is one of the deadliest cancers in the world. Two of the most common subtypes, lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), have drastically different biological signatures, yet they are often treated similarly and classified together as non-small cell lung cancer...
Autores principales: | Chen, Joe W., Dhahbi, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233431/ https://www.ncbi.nlm.nih.gov/pubmed/34172784 http://dx.doi.org/10.1038/s41598-021-92725-8 |
Ejemplares similares
-
Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma
por: Cao, Bingji, et al.
Publicado: (2021) -
Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021) -
Identification of Biomarkers for Esophageal Squamous Cell Carcinoma Using Feature Selection and Decision Tree Methods
por: Tung, Chun-Wei, et al.
Publicado: (2013) -
Classification and survival prediction for early-stage lung adenocarcinoma and squamous cell carcinoma patients
por: Tian, Suyan
Publicado: (2017) -
Identification of Subtype-Specific Prognostic Genes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients Using an Embedded Feature Selection Algorithm
por: Tian, Suyan
Publicado: (2015)